| scholarly article | Q13442814 |
| retracted paper | Q45182324 |
| P356 | DOI | 10.1016/S1097-2765(03)00276-4 |
| P698 | PubMed publication ID | 14536082 |
| P50 | author | Huda Zoghbi | Q1633764 |
| Irina Stancheva | Q30505459 | ||
| Richard Meehan | Q42846183 | ||
| P2093 | author name string | Anne L Collins | |
| Ingatia B Van den Veyver | |||
| P2860 | cites work | Early neurogenesis in Xenopus: the spatio-temporal pattern of proliferation and cell lineages in the embryonic spinal cord | Q46228698 |
| Molecular targets of vertebrate segmentation: two mechanisms control segmental expression of Xenopus hairy2 during somite formation | Q48333452 | ||
| The Vi element. A transposon-like repeated DNA sequence interspersed in the vitellogenin locus of Xenopus laevis | Q48372410 | ||
| Intrinsic differences between the superficial and deep layers of the Xenopus ectoderm control primary neuronal differentiation | Q48559576 | ||
| DNA methylation patterns and epigenetic memory | Q22065780 | ||
| Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2 | Q22337290 | ||
| The Ski protein family is required for MeCP2-mediated transcriptional repression | Q24291417 | ||
| Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex | Q24324026 | ||
| Nuclear localization of CBF1 is regulated by interactions with the SMRT corepressor complex | Q24550850 | ||
| A histone deacetylase corepressor complex regulates the Notch signal transduction pathway | Q24598533 | ||
| Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA | Q28265233 | ||
| Species-specific organization of CpG island promoters at mammalian homologous genes | Q28343947 | ||
| A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome | Q28504458 | ||
| MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin | Q28576622 | ||
| Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription | Q29547568 | ||
| Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice | Q29616328 | ||
| Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3 | Q29616516 | ||
| Appendix G: In Situ Hybridization: An Improved Whole-Mount Method for Xenopus Embryos | Q29620084 | ||
| Functional consequences of Rett syndrome mutations on human MeCP2. | Q33826022 | ||
| Co-localization of Polycomb protein and GAGA factor on regulatory elements responsible for the maintenance of homeotic gene expression | Q33886885 | ||
| Rett syndrome: methyl-CpG-binding protein 2 mutations and phenotype-genotype correlations | Q34141668 | ||
| Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changes in the brain | Q34387585 | ||
| Methyl CpG-binding proteins and transcriptional repression | Q34464674 | ||
| Neurogenesis in embryos and in adult neural stem cells. | Q34516002 | ||
| Vertebrate hairy and Enhancer of split related proteins: transcriptional repressors regulating cellular differentiation and embryonic patterning | Q34526571 | ||
| DNA methylation in animal development | Q35043702 | ||
| In vivo repression of an erythroid-specific gene by distinct corepressor complexes | Q39644809 | ||
| Loss of the maintenance methyltransferase, xDnmt1, induces apoptosis in Xenopus embryos | Q39645050 | ||
| Loss of genomic methylation causes p53-dependent apoptosis and epigenetic deregulation | Q40834659 | ||
| DNA methylation at promoter regions regulates the timing of gene activation in Xenopus laevis embryos | Q43887369 | ||
| P433 | issue | 2 | |
| P921 | main subject | Rett syndrome | Q917357 |
| P304 | page(s) | 425-435 | |
| P577 | publication date | 2003-08-01 | |
| P1433 | published in | Molecular Cell | Q3319468 |
| P1476 | title | A mutant form of MeCP2 protein associated with human Rett syndrome cannot be displaced from methylated DNA by notch in Xenopus embryos | |
| P478 | volume | 12 |
| Q45660411 | A case of a Tunisian Rett patient with a novel double-mutation of the MECP2 gene. |
| Q34307505 | A previously unidentified MECP2 open reading frame defines a new protein isoform relevant to Rett syndrome |
| Q30442429 | A suppressor screen in Mecp2 mutant mice implicates cholesterol metabolism in Rett syndrome |
| Q48543830 | Aberrant epigenetic landscape in intellectual disability. |
| Q35789585 | Advances in chromatin remodeling and human disease |
| Q33996223 | Affinity-based enrichment strategies to assay methyl-CpG binding activity and DNA methylation in early Xenopus embryos. |
| Q37962183 | Algorithmic approach for methyl-CpG binding protein 2 (MECP2) gene testing in patients with neurodevelopmental disabilities |
| Q35910320 | Altered epigenetic signals in human disease. |
| Q57239828 | An increase in MECP2 dosage impairs neural tube formation |
| Q28591033 | Analysis of protein domains and Rett syndrome mutations indicate that multiple regions influence chromatin-binding dynamics of the chromatin-associated protein MECP2 in vivo |
| Q28256313 | Association by guilt: identification of DLX5 as a target for MeCP2 provides a molecular link between genomic imprinting and Rett syndrome |
| Q37867211 | Biological functions of methyl-CpG-binding proteins |
| Q24303656 | CDKL5 belongs to the same molecular pathway of MeCP2 and it is responsible for the early-onset seizure variant of Rett syndrome |
| Q42861195 | CHD4/Mi-2beta activity is required for the positioning of the mesoderm/neuroectoderm boundary in Xenopus |
| Q34200572 | Cell-autonomous alterations in dendritic arbor morphology and connectivity induced by overexpression of MeCP2 in Xenopus central neurons in vivo |
| Q28238925 | Chromatin remodeling and neuronal function: exciting links |
| Q38375116 | Clinical and biological progress over 50 years in Rett syndrome. |
| Q28509434 | Components of the DNA methylation system of chromatin control are RNA-binding proteins |
| Q35096766 | Corepressors, nuclear receptors, and epigenetic factors on DNA: a tail of repression |
| Q40378884 | DNA binding selectivity of MeCP2 due to a requirement for A/T sequences adjacent to methyl-CpG. |
| Q36008099 | DNA methylation 40 years later: Its role in human health and disease |
| Q35203203 | DNA methylation and Rett syndrome |
| Q37311875 | DNA methylation and methyl-CpG binding proteins: developmental requirements and function |
| Q46291986 | DNA methylation controls the timing of astrogliogenesis through regulation of JAK-STAT signaling. |
| Q38053796 | DNA methylation: new therapeutic implications for hepatic fibrosis |
| Q46370352 | Defects in brainstem neurons associated with breathing and motor function in the Mecp2R168X/Y mouse model of Rett syndrome |
| Q26768284 | Developmental Dynamics of Rett Syndrome |
| Q38337932 | Developmental stage dependent regulation of DNA methylation and chromatin modification in a immature astrocyte specific gene promoter. |
| Q45140260 | Differential expression of the methyl-cytosine binding protein 2 gene in embryonic and adult brain of zebrafish |
| Q36286552 | Dissecting MECP2 function in the central nervous system |
| Q48959692 | Distinct expression profiles of Mecp2 transcripts with different lengths of 3'UTR in the brain and visceral organs during mouse development |
| Q38346038 | Elevated expression of MeCP2 in cardiac and skeletal tissues is detrimental for normal development |
| Q42139270 | Elevating expression of MeCP2 T158M rescues DNA binding and Rett syndrome-like phenotypes. |
| Q38142479 | Embryonic DNA methylation: insights from the genomics era. |
| Q36164746 | Epigenetic regulation of lymphoid specific gene sets |
| Q24568049 | Expression of MeCP2 in postmitotic neurons rescues Rett syndrome in mice |
| Q33251357 | Expression profiling of clonal lymphocyte cell cultures from Rett syndrome patients |
| Q50053045 | First report of an unusual novel double mutation affecting the transcription repression domain of MeCP2 and causing a severe phenotype of Rett syndrome: Molecular analyses and computational investigation |
| Q48184435 | Functional analysis of Hairy genes in Xenopus neural crest initial specification and cell migration. |
| Q38100616 | Functional implications of hippocampal adult neurogenesis in intellectual disabilities |
| Q37236200 | Gene clusters, molecular evolution and disease: a speculation |
| Q28290773 | Genomic DNA methylation: the mark and its mediators |
| Q63255985 | Hairy2–Id3 interactions play an essential role in Xenopus neural crest progenitor specification |
| Q27316790 | Hypoxic regulation of hand1 controls the fetal-neonatal switch in cardiac metabolism |
| Q48924208 | Increased dendritic complexity and axonal length in cultured mouse cortical neurons overexpressing methyl-CpG-binding protein MeCP2. |
| Q24685599 | Inhibitors of differentiation (ID1, ID2, ID3 and ID4) genes are neuronal targets of MeCP2 that are elevated in Rett syndrome |
| Q28293919 | Kaiso is a genome-wide repressor of transcription that is essential for amphibian development |
| Q38514045 | Kaiso/p120-catenin and TCF/beta-catenin complexes coordinately regulate canonical Wnt gene targets |
| Q35838075 | Linking epigenetics to human disease and Rett syndrome: the emerging novel and challenging concepts in MeCP2 research |
| Q36959606 | MECP2 genomic structure and function: insights from ENCODE |
| Q28511729 | MECP2 is progressively expressed in post-migratory neurons and is involved in neuronal maturation rather than cell fate decisions |
| Q38853829 | MECP2, a multi-talented modulator of chromatin architecture |
| Q37468796 | Many paths to one goal? The proteins that recognize methylated DNA in eukaryotes |
| Q24315524 | Mastermind recruits CycC:CDK8 to phosphorylate the Notch ICD and coordinate activation with turnover |
| Q24602300 | Mbd1 is recruited to both methylated and nonmethylated CpGs via distinct DNA binding domains |
| Q42372796 | MeCP2 Deficiency in Neuroglia: New Progress in the Pathogenesis of Rett Syndrome |
| Q48841317 | MeCP2 R168X male and female mutant mice exhibit Rett-like behavioral deficits |
| Q40523652 | MeCP2 behaves as an elongated monomer that does not stably associate with the Sin3a chromatin remodeling complex |
| Q37530120 | MeCP2 co-ordinates liver lipid metabolism with the NCoR1/HDAC3 corepressor complex |
| Q28593334 | MeCP2 deficiency in Rett syndrome causes epigenetic aberrations at the PWS/AS imprinting center that affects UBE3A expression |
| Q28243423 | MeCP2 in neurons: closing in on the causes of Rett syndrome |
| Q28256925 | MeCP2: the chromatin connection and beyond |
| Q28260093 | Mechanisms of disease: neurogenetics of MeCP2 deficiency |
| Q28595061 | Mecp2 deficiency is associated with learning and cognitive deficits and altered gene activity in the hippocampal region of mice |
| Q28593320 | Mecp2 deficiency leads to delayed maturation and altered gene expression in hippocampal neurons |
| Q40967665 | Mecp2 regulates neural cell differentiation by suppressing the Id1 to Her2 axis in zebrafish |
| Q46968822 | Mecp2 regulates tnfa during zebrafish embryonic development and acute inflammation |
| Q36387350 | Methyl-CpG Binding Protein 2 (Mecp2) Regulates Sensory Function Through Sema5b and Robo2 |
| Q36109301 | Methyl-CpG binding proteins in the nervous system |
| Q33864653 | Methyl-CpG binding proteins: specialized transcriptional repressors or structural components of chromatin? |
| Q73927307 | Methylation gets SMRT. Functional insights into Rett syndrome |
| Q90605935 | MicroRNA-197 controls ADAM10 expression to mediate MeCP2's role in the differentiation of neuronal progenitors |
| Q28552209 | Misregulation of Alternative Splicing in a Mouse Model of Rett Syndrome |
| Q38806507 | Modeling Rett Syndrome Using Human Induced Pluripotent Stem Cells |
| Q37137731 | Modeling human neurodevelopmental disorders in the Xenopus tadpole: from mechanisms to therapeutic targets |
| Q26742136 | Modifiers and Readers of DNA Modifications and Their Impact on Genome Structure, Expression, and Stability in Disease |
| Q48156888 | Molecular biology. MeCP2 repression goes nonglobal |
| Q28240924 | Molecular genetics of Rett syndrome: when DNA methylation goes unrecognized |
| Q35911131 | Mutation of MeCP2 alters transcriptional regulation of select immediate-early genes |
| Q24534159 | Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5/STK9) gene are associated with severe neurodevelopmental retardation |
| Q36449308 | Neural stem cell self-renewal |
| Q47846203 | Neuronal differentiation of neural precursor cells is promoted by the methyl-CpG-binding protein MeCP2. |
| Q35180703 | Neuronal maturation defect in induced pluripotent stem cells from patients with Rett syndrome |
| Q38089266 | Non-canonical functions of the DNA methylome in gene regulation |
| Q33343524 | Notch signaling in cancer. |
| Q36401283 | Notch signaling. |
| Q35893511 | Notch signaling: the demise of elegant simplicity |
| Q41313168 | Novel alterations in the epigenetic signature of MeCP2-targeted promoters in lymphocytes of Rett syndrome patients |
| Q39001885 | Novel mutations in the C-terminal region of the MECP2 gene in Tunisian Rett syndrome patients |
| Q35802810 | Nuclear receptor recruitment of histone-modifying enzymes to target gene promoters |
| Q41967315 | Putting muscle in DNA methylation |
| Q52049234 | REST and its corepressors mediate plasticity of neuronal gene chromatin throughout neurogenesis. |
| Q36238523 | Reading the DNA methylation signal |
| Q39392020 | Reduced expression of MECP2 affects cell commitment and maintenance in neurons by triggering senescence: new perspective for Rett syndrome |
| Q51585441 | Regulation of myofibroblast transdifferentiation by DNA methylation and MeCP2: implications for wound healing and fibrogenesis. |
| Q36434812 | Replication and translation of epigenetic information. |
| Q33901030 | Respiratory phenotypes are distinctly affected in mice with common Rett syndrome mutations MeCP2 T158A and R168X. |
| Q28511624 | Rett syndrome mutations abolish the interaction of MeCP2 with the NCoR/SMRT co-repressor |
| Q38366899 | Rett syndrome: a complex disorder with simple roots |
| Q28255289 | Rett syndrome: a prototypical neurodevelopmental disorder |
| Q35953005 | Rett syndrome: clinical and molecular update |
| Q24674633 | Rett syndrome: clinical review and genetic update |
| Q88609435 | Rett syndrome: insights into genetic, molecular and circuit mechanisms |
| Q36545755 | Rett syndrome: new clinical and molecular insights. |
| Q33915332 | Rett-causing mutations reveal two domains critical for MeCP2 function and for toxicity in MECP2 duplication syndrome mice |
| Q28589681 | SMRT-mediated repression of an H3K27 demethylase in progression from neural stem cell to neuron |
| Q46778398 | Serotonin transporter abnormality in the dorsal motor nucleus of the vagus in Rett syndrome: potential implications for clinical autonomic dysfunction |
| Q37859094 | Strategies for DNA methylation analysis in developmental studies |
| Q33594773 | Structure of the MeCP2-TBLR1 complex reveals a molecular basis for Rett syndrome and related disorders |
| Q64072871 | Tapping-lips aggravated interictal bilateral discharges in EEG in the patients with Rett syndrome: a case report |
| Q35145517 | Temporal uncoupling of the DNA methylome and transcriptional repression during embryogenesis |
| Q33737461 | The Crucial Role of DNA Methylation and MeCP2 in Neuronal Function |
| Q52042590 | The Notch targets Esr1 and Esr10 are differentially regulated in Xenopus neural precursors. |
| Q33236148 | The X-linked methyl binding protein gene Kaiso is highly expressed in brain but is not mutated in Rett syndrome patients |
| Q40548681 | The cell-specific expression of endothelial nitric-oxide synthase: a role for DNA methylation. |
| Q51935592 | The impact of MECP2 mutations in the expression patterns of Rett syndrome patients. |
| Q28511496 | The major form of MeCP2 has a novel N-terminus generated by alternative splicing |
| Q24301882 | The methyl-CpG binding protein MBD1 is required for PML-RARalpha function |
| Q33403744 | The methyl-CpG binding proteins Mecp2, Mbd2 and Kaiso are dispensable for mouse embryogenesis, but play a redundant function in neural differentiation |
| Q35535125 | The methyl-CpG-binding domain (MBD) is crucial for MeCP2's dysfunction-induced defects in adult newborn neurons |
| Q36425877 | The transcriptional corepressor SMRTER influences both Notch and ecdysone signaling during Drosophila development |
| Q28588081 | The transcriptional repressor Mecp2 regulates terminal neuronal differentiation |
| Q33621937 | Therapeutic targeting of NOTCH1 signaling in T-cell acute lymphoblastic leukemia |
| Q48364148 | Thyroid function in Rett syndrome |
| Q39960021 | Transcriptional activation by the Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen is facilitated by an N-terminal chromatin-binding motif. |
| Q36053034 | Transcriptional activities of retinoic acid receptors |
| Q36049187 | Transcriptional control of cognitive development |
| Q53465855 | Using Morpholinos to control gene expression. |
| Q35789580 | When enough is enough: genetic diseases associated with transcriptional derepression |
| Q56270643 | X-linked mental retardation |
| Q46962711 | Xenopus embryos lacking specific isoforms of the corepressor SMRT develop abnormal heads. |
| Q51988923 | Xenopus hairy2 functions in neural crest formation by maintaining cells in a mitotic and undifferentiated state. |
Search more.